The board of directors of May & Baker Nigeria Plc has appointed Senator Daisy Danjuma as the chairman of the company. She succeeded Lt General Theophilus Danjuma who retired on September 27, 2019 after 16 years as director and chairman of board of directors of May & Baker Nigeria Plc.
Directors of the healthcare company, at their meeting on September 27, 2019, appointed Daisy Danjuma to lead the company. She was first appointed to the board of directors of the healthcare company on July 30, 1999 and retired on October 8, 2003 and was later reappointed on May 30, 2019.
She brings to the leadership of the board of the healthcare company over 42 years wealth of experience in legal, administrative and public service. A 1976 law graduate of the Ahmadu Bello University (ABU), Zaria, she was called to the Nigerian bar in 1977. She was chairman board of directors, South Atlantic Petroleum Limited between 1999 and 2003 and currently the executive vice chairman of the company.
She worked as a State Counsel with the Lagos State Ministry of Justice in the office of the Director of Public Prosecutions (DPP). She was a pioneer legal counsel to the Legal Aid Council and later worked as the company secretary and legal adviser to the Nigerian Television Authority (NTA) between 1982 and 1992.
Between 2003 and 2007 she served as a Senator of the Federal Republic of Nigeria. As a Senator, she was Chairman Women and Child Rights Committee of the Economic Community of West African States, (ECOWAS), Chairman Senate Committee on Women Affairs and Youth Development and a member of the Commonwealth Parliamentary Association. She also served as a member of the Senate Committees on Health, Education, Finance and Land Transport.
An alumnus of the Lagos Business School (LBS), a member of the International Bar Association, the Nigerian Bar Association, and the International Federation of Women Lawyers, Senator Daisy Danjuma is also the Chairman of Board of Trustees of Lagos Public Interest Law Partnership, and Trustee of the H.I.D Awolowo Foundation.
Market analysts have applauded the contributions of Theophilus Danjuma to the strengthening of May & Baker Nigeria as a leading healthcare company in nearly two decades despite the challenges in the operating environment.
Danjuma, who was appointed to the board of the healthcare company in 2003, led the company to many landmarks including the construction of one of the largest pharmaceutical manufacturing facilities in Sub-Saharan Africa, The Pharma Complex of May & Baker Nigeria. The Pharma Complex is certified by the World Health Organization (WHO) for Good Manufacturing Practice, one of the few African drug production companies to be so qualified.
He also led the company in pioneering expansion into crucial areas of the healthcare industry including the perfection of a joint venture with the Federal Government of Nigeria to set up West Africa’s first private vaccine production company, Biovaccines Nigeria Limited.
From a turnover of about N1 billion, Danjuma grew the company to a turnover of about N10 billion with steady profit and dividend records. Under him, May & Baker Nigeria won many national and international laurels including the National Productivity Order of Merit Award, 2018.
A retired soldier, administrator and business mogul, Danjuma had served on the boards of several companies. He has several national and international awards including the Grand Commander of the Order of the Niger (GCON) and National Honours of Somalia and Poland.
A philanthropist, he is the founder and promoter of TY Danjuma Foundation, a leading philanthropic organisation focused on the wellbeing of the less privileged and the general good of the society.